Leadership Infrastructure Accelerator™
An ongoing partnership for leadership teams who want a fractional executive in the room, not a project that ends.
What this is
An ongoing, 6-12 month partnership delivered in successive 90-day phases — a fractional executive presence for leadership teams navigating sustained growth or complexity, not a single fixed-scope project. Each phase runs the same disciplined BRIDGE Process the shorter tiers use once; here, it repeats, recalibrating each time against what's actually showing up.
Who it's for
Leadership teams heading into a growth phase their current organization wasn't built to support, who need sustained executive-level partnership rather than a one-time engagement — doubling headcount, rebuilding an underperforming leadership team, or preparing for a commercial launch.
- Successive 90-day phases, each following the full BRIDGE Process
- Ongoing fractional-executive presence, not just periodic check-ins
- Continuous recalibration as the organization's needs evolve
- Embedded capability at every phase, so the partnership builds lasting infrastructure
Successive 90-day phases, not a single sprint
First 90 Days
A full BRIDGE cycle establishes the foundation — current-state clarity, a named set of gaps, and the first round of embedded capability.
Recalibrate & Extend
As the organization's needs shift, the next 90-day phase is re-scoped against what's actually showing up, not the original static assumptions.
Sustained Partnership
Through month 12, a continued fractional-executive presence — each successive phase building on what the last one embedded.
For growth that won't fit in one sprint
Choose the Accelerator when the complexity ahead is likely to keep evolving past a single 90-day window — not a one-time fix. If the need is bounded and already well-defined, the 90-Day Transformation Solution delivers the same rigor as a fixed-scope sprint. See Methodology for how the Leadership Infrastructure Framework™ and BRIDGE Process work end to end.
Protected Deal Value During a $140M Acquisition
A Series B-funded life sciences company integrating post-acquisition faced cultural misalignment and compliance exposure that threatened deal value. A phased integration — due diligence, a full cultural assessment, and a unified structure — held 75% retention through the first 18 months and 83% favorable engagement scores one year after close.
Read the case study →